- Home
- PHIO vs HSDT Comparison
PHIO vs HSDT Comparison
Compare PHIO & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- HSDT
- Stock Information
- Founded
- PHIO 2011
- HSDT 2014
- Country
- PHIO United States
- HSDT United States
- Employees
- PHIO N/A
- HSDT N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PHIO Health Care
- HSDT Health Care
- Exchange
- PHIO Nasdaq
- HSDT Nasdaq
- Market Cap
- PHIO 2.3M
- HSDT 2.5M
- IPO Year
- PHIO N/A
- HSDT N/A
- Fundamental
- Price
- PHIO $2.61
- HSDT $0.49
- Analyst Decision
- PHIO Strong Buy
- HSDT Buy
- Analyst Count
- PHIO 1
- HSDT 2
- Target Price
- PHIO $36.00
- HSDT $24.00
- AVG Volume (30 Days)
- PHIO 30.8K
- HSDT 236.6K
- Earning Date
- PHIO 11-14-2024
- HSDT 11-12-2024
- Dividend Yield
- PHIO N/A
- HSDT N/A
- EPS Growth
- PHIO N/A
- HSDT N/A
- EPS
- PHIO N/A
- HSDT N/A
- Revenue
- PHIO N/A
- HSDT $502,000.00
- Revenue This Year
- PHIO N/A
- HSDT N/A
- Revenue Next Year
- PHIO N/A
- HSDT $8.97
- P/E Ratio
- PHIO N/A
- HSDT N/A
- Revenue Growth
- PHIO N/A
- HSDT N/A
- 52 Week Low
- PHIO $2.17
- HSDT $0.37
- 52 Week High
- PHIO $10.35
- HSDT $9.50
- Technical
- Relative Strength Index (RSI)
- PHIO 48.74
- HSDT 44.03
- Support Level
- PHIO $2.58
- HSDT $0.43
- Resistance Level
- PHIO $2.91
- HSDT $0.76
- Average True Range (ATR)
- PHIO 0.21
- HSDT 0.08
- MACD
- PHIO 0.01
- HSDT -0.01
- Stochastic Oscillator
- PHIO 26.76
- HSDT 17.91
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.